AMENDMENT NO. 1 TO DEPOSIT AGREEMENTDeposit Agreement • October 21st, 2024 • Radiopharm Theranostics LTD • Pharmaceutical preparations • New York
AMENDMENT No. 1 (the “Amendment”) dated as of October __, 2024 to the Deposit Agreement (the “Effective Date”), dated as of September 18, 2024 (as amended from time to time, the “Deposit Agreement”), by and among (i) Radiopharm Theranostics Limited, a company incorporated in the Commonwealth of Australia (together with its successors, the “Company”), (ii) Deutsche Bank Trust Company Americas, an indirect wholly owned subsidiary of Deutsche Bank A.G., acting in its capacity as depositary, and any successor depositary hereunder (the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares evidenced by American Depositary Receipts issued thereunder.
MASTER SERVICE AGREEMENTMaster Service Agreement • October 21st, 2024 • Radiopharm Theranostics LTD • Pharmaceutical preparations • York
This Master Service Agreement (the “Agreement”), effective as of September 30, 2024 (the “Effective Date”), is established between AtomVie Global Radiopharma Inc., a corporation incorporated under the laws of Canada with offices located at McMaster University, Nuclear Research Building A316, 1280 Main Street West, Hamilton, Ontario, Canada, L8S 4K1, (“AtomVie”), and Radiopharm Theranostics Limited, ACN: 647877889 (RAD) (“CLIENT”), having a place of business at Suite 1, Level 3, 62 Lygon St, Carlton South, VIC, 3053, Australia, to define the general conditions to govern any contracted services to be undertaken for CLIENT by AtomVie. In this Agreement, CLIENT and AtomVie may be referred to individually each as “Party” or collectively as the “Parties.”
